"10.1371_journal.pone.0062115","plos one","2013-04-12T00:00:00Z","Reid A Roberts; Tammy Shen; Irving C Allen; Warefta Hasan; Joseph M DeSimone; Jenny P Y Ting","Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, United States of America; Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, United States of America; Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, United States of America; Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina, United States of America; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America; Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina, United States of America; Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina, Chapel Hill, North Carolina, United States of America; Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, United States of America; Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina, United States of America; Institute for Advanced Materials, University of North Carolina, Chapel Hill, North Carolina, United States of America; Institute for Nanomedicine, University of North Carolina, Chapel Hill, North Carolina, United States of America; Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America","Supervised the overall research project: JPYT JMDS. Conceived and designed the experiments: RAR. Performed the experiments: RAR ICA TS. Analyzed the data: RAR ICA TS. Contributed reagents/materials/analysis tools: TS WH. Wrote the paper: RAR.","Joseph M. DeSimone is a founder, member of the board of directors, and maintains a financial interest in Liquidia Technologies. PRINT and Fluorocur are registered trademarks of Liquidia Technologies, Inc. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials created by the authors. One author, Warefta Hasan, is currently employed by a commercial company but she was an employee of the University of North Carolina at the time of the studies detailed in this manuscript. She does not have any competing interests and her current commercial employment does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials created by the authors.","2013","04","Reid A Roberts","RAR",6,TRUE,1,3,3,1,TRUE,TRUE,FALSE,0,NA,FALSE
